Osteolysis in Transforaminal Lumbar Interbody Fusion with Bone Morphogenetic Protein-2

被引:58
作者
Knox, Jeffrey B. [1 ]
Dai, Joseph M., III [1 ]
Orchowski, Joseph [1 ]
机构
[1] Tripler Army Med Ctr, Orthoped Surg Serv, Dept Surg, Honolulu, HI 96859 USA
关键词
osteolysis; BMP; interbody fusion; complication; osteobiologics; POSTERIOR ILIAC CREST; PROTEIN-2/COMPRESSION RESISTANT MATRIX; CLINICAL-OUTCOMES; SPINAL-FUSION; COMPLICATIONS; RHBMP-2; ANTERIOR; ALLOGRAFT; RATES;
D O I
10.1097/BRS.0b013e3181e030e0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Design. Retrospective radiographic review. Objective. To determine the incidence of osteolysis, graft subsidence, and cage migration after recombinant human bone morphogenetic protein-2 (rhBMP-2) use with transforaminal lumbar interbody fusion (TLIF). Summary of Background Data. Osteolysis after TLIF is a recently described phenomenon associated with rhBMP-2 use. Although this is typically a self-limiting condition, complications such as graft subsidence and cage migration have been described. The incidence of this is not well defined and most studies use plain radiographs for diagnosis rather than more advanced imaging. This study serves to quantify the risk of osteolysis and its associated graft complications with routine use of computed tomography. Methods. A total of 58 patients who underwent primary TLIF from a single surgeon between 2004 and 2007 underwent routine postoperative computed tomographic scan. Seventy-seven levels of fusion were evaluated for osteolysis. All patients received the same dose of rhBMP-2 of 5 mg per level. Imaging was performed immediately postoperative and again at an average of 4.3 months postoperative (range = 2.4-9.0 months). These images were evaluated for the presence of osteolysis, graft subsidence, and cage migration. These changes were then graded according to their severity. Results. Osteolysis was found in 16 of the 58 (27.6%) patients and 19 of the 77 (24.7%) levels treated. No significant difference was found between single and two-level fusions. The degree of osteolysis ranged from 3 to 20 mm with an average of 12.5 mm. The osteolysis was characterized as severe (> 1 cm) in 12 of the 19 levels. Of the patients with osteolysis, 31.6% demonstrated graft subsidence all of which occurred with severe osteolytic defects. Migration of the intervertebral cage was found in 8.8% of patients. Conclusion. rhBMP-2 use with TLIF is associated with a significant risk of postoperative osteolysis. Patients who demonstrated postoperative osteolysis were associated with significant risk of subsidence or migration of the intervertebral cage. The clinical implications of these changes are not currently known.
引用
收藏
页码:672 / 676
页数:5
相关论文
共 35 条
[1]   Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes [J].
Ahlmann, E ;
Patzakis, M ;
Roidis, N ;
Shepherd, L ;
Holtom, P .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2002, 84A (05) :716-720
[2]   Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans - A prospective, randomized clinical pilot trial - 2002 Volvo Award in clinical studies [J].
Boden, SD ;
Kang, J ;
Sandhu, H ;
Heller, JG .
SPINE, 2002, 27 (23) :2662-2673
[3]   Prevalence, Complications, and Hospital Charges Associated With Use of Bone-Morphogenetic Proteins in Spinal Fusion Procedures [J].
Cahill, Kevin S. ;
Chi, John H. ;
Day, Arthur ;
Claus, Elizabeth B. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (01) :58-66
[4]   Pelvic instability after bone graft harvesting from posterior iliac crest: report of nine patients [J].
Chan, K ;
Resnick, D ;
Pathria, M ;
Jacobson, J .
SKELETAL RADIOLOGY, 2001, 30 (05) :278-281
[5]   Recombinant Human Bone Morphogenetic Protein-2 on an Absorbable Collagen Sponge with an Osteoconductive Bulking Agent in Posterolateral Arthrodesis with Instrumentation A Prospective Randomized Trial [J].
Dawson, Edgar ;
Bae, Hyun W. ;
Burkus, J. Kenneth ;
Stambough, Jeffery L. ;
Glassman, Steven D. .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2009, 91A (07) :1604-1613
[6]   Clinical and radiographic comparison of mini-open transforaminal lumbar interbody fusion with open transforaminal lumbar interbody fusion in 42 patients with long-term follow-up [J].
Dhall, Sanjay S. ;
Wang, Michael Y. ;
Mummaneni, Praveen V. .
JOURNAL OF NEUROSURGERY-SPINE, 2008, 9 (06) :560-565
[7]   Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft [J].
Dimar, John R. ;
Glassman, Steven D. ;
Burkus, Kenneth J. ;
Carreon, Leah Y. .
SPINE, 2006, 31 (22) :2534-2539
[8]   Clinical and Radiographic Analysis of an Optimized rhBMP-2 Formulation as an Autograft Replacement in Posterolateral Lumbar Spine Arthrodesis [J].
Dimar, John R., II ;
Glassman, Steven D. ;
Burkus, J. Kenneth ;
Pryor, Philip W. ;
Hardacker, James W. ;
Carreon, Leah Y. .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2009, 91A (06) :1377-1386
[9]   Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion [J].
Glassman, SD ;
Dimar, JR ;
Carreon, LY ;
Campbell, MJ ;
Puno, RM ;
Johnson, JR .
SPINE, 2005, 30 (15) :1694-1698
[10]   Radiographic and Clinical Outcomes After Instrumented Reduction and Transforaminal Lumbar Interbody Fusion of Mid and High-grade Isthmic Spondylolisthesis [J].
Goyal, Nitin ;
Wimberley, David W. ;
Hyatt, Adam ;
Zeiller, Steve ;
Vaccaro, Alexander R. ;
Hilibrand, Alan S. ;
Albert, Todd J. .
JOURNAL OF SPINAL DISORDERS & TECHNIQUES, 2009, 22 (05) :321-327